Zentec

Early diagnostic for a better life

ZenTech is a Belgian biotechnology company specialized in the development, production and marketing of IVD kits specifically developed for prenatal, neonatal and pediatric use.

Read more

  • Prenatalogy

    "The most flexible Down's syndrome screening program"
    Prenatal diagnostic of Down’s Syndrome and other chromosomal abnormalities is based on foetal karyotyping. Because of costs and risks associated with amniocentesis, karyotyping is restricted to patients at increased risk.

    Read more

  • Neonatalogy

    "Using Dried Blood Spots samples (DBS)..."
    There are 1.876 billion children aged 0 to 15 years in the world. Although they account for 28% of the human population, they do not always have access to therapies and diagnostics specifically adapted to their physiology.

    Read more

  • Pediatric

    "Diagnostic products adapted to children..."
    ZenTech's vision is to come up with adapted In Vitro Diagnostic solutions using less or non-invasive sampling methods, and to provide a wide range of diagnostic pediatrics products...

    Read more

  • Automates

    Automated systems for immunoassays, from sampling to results...: ELAPlatform Maxi, Midi & Mini • Cytogenetics: a unique instrument for karyotyping preparation on slides, the Zendropper • Rapid tests reader, beyond reading...

    Read more

  • Others

    Myeloperoxidase, a new biomarker of inflammation... • Immune system: getting better neuropathies diagnosis with Dotzen Ganglio Profile Ab • For research use only (CRO): immunoassays for animal hormones & peptides • Services: contract & OEM manufacturing, laboratory services

    Read more



  • News & Events

    Read all news
  • 04/26/13
    ZenTech in ASEAN

    ZENTECH BIOTECHNOLOGY ASIA, based in Singapore, has been incorporated. After our presence in Vietnam and Philippines, it is a major step in our developments in ASIA and more particularly in ASEAN.

    More
  • 04/16/13
    2013 Newborn Screening Meeting

    Mr. Alain Bosseloir, our Chief Operative Officer (COO), will be present on May 5–10, 2013 at 'Atlanta Marriott Marquis' in Atlanta, GA, for the Joint Meeting of the Newborn Screening and Genetic Testing Symposium (NBSGTS) and International Society for Neonatal Screening (ISNS).

    More